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Abstract Introduction: Resource 
limitation in developing countries 
may preclude access to cardiac tro-
ponin-T assay thereby necessitating 
reliance on clinical judgment for 
identification of hypoxic myocar-
dial cellular injury. 
Objectives: To relate selected clini-
cal signs with elevated serum car-
diac troponin-T in asphyxiated term 
neonates. 
Methods: Asphyxia was identified 
by low umbilical arterial blood pH 
≤ 7.20 and low five minute Apgar 
score ≤ 6 while controls were term, 
non–asphyxiated neonates. All ba-
bies were examined for heart rate, 
heart rhythm irregularities, periph-
eral pulse volume, respiratory rate, 
pallor, cyanosis, heart murmur and 
sensorium. 
Results: Thirty term, asphyxiated 
neonates and their matched controls 
were studied. Central cyanosis, re-
duced pulse volume, pallor, de-
pressed sensorium; tachycardia and 
tachypnea were all associated with 
increased odds ratios for abnormal 
cardiac troponin–T levels.  
Conclusion: Clinicians working in 
resource–limited health facilities 
should have a high index of suspi-
cion for myocardial cellular injury 
when these signs are elicited.  
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Perinatal asphyxia is one of the leading causes of ne na-
tal deaths in Nigeria where up to 100 – 180 per thousand 
live births are affected.1-3 Severe perinatal asphyxia has 
been known to cause ischaemic myocardial injury with 
potentially fatal outcomes.4-6 Serum cardiac troponin T 
(cTnT) is a reliable marker of myocardial injury.7 In 
spite of the significant burden of perinatal asphyxia in 
our practice, many health facilities cannot afford the 
necessary equipment for assessment of serum cTnT.  
 
Following an asphyxia event, the dive reflex prefern-
tially sustains vital organ perfusion (heart, brain d 
adrenals) but as asphyxia progresses, these vital org ns 
including the heart eventually become compromised.8 
The cardiovascular damage that ensues is related to 
cerebral damage as well as neonatal death4-6 Some of the 
clinical features of cardiovascular injury include atrio-
ventricular valve regurgitation, hypotension, bradycar-
dia, tachycardia and shock.9 Troponin is an inhibitory 
protein complex located on the actin filament of the  
cardiac muscle and is elaborated in cardiac damage.10 
Troponin-T (cTnT) is specific for myocardial injury and 
is unaffected by, mode of delivery, birth weight and 
gender.11Previous studies have noted a significant rela-
tionship of troponin T levels with the use of vasopres-
sors.12-14.  This may not be unconnected to the various 
degrees of shock that necessitated the use of the vaso-
pressors in the studied neonates. However studies that 
relate cTnT directly to signs such as pallor, cyanosis, 
tachypnoea, tachycardia, low pulse volume and de-
pressed sensorium could not be found by our search.  
The authors have previously reported the serum levels of 
serum cardiac troponin T in term newborns and demon-
strated that myocardial damage does occur perinatal 
asphyxia.6 However, we are aware that resource limita-
tion may preclude access to cardiac troponin assay in 
many of our practice settings. It is therefore important to 
examine the inter-relationship of cardiovascular sign  
with serum cardiac troponin levels. Hence we set out t  
correlate the occurrence of elevated serum cTnT (and 
hence myocardial injury) with selected clinical parame-
ters including the heart rate, respiratory rate, periph ral 
pulse volume, heart rhythm irregularities, pallor, cyano-
sis, heart murmur and sensorium. Of particular interest 
was to identify high risk clinical pointers for elevated 
serum cTnT that could be used to enhance the diagnosis 





Subjects and methods 
 
Cases and controls were recruited from the delivery 
rooms and neonatal intensive care units (NICU) of the 
Lagos University Teaching Hospital (LUTH) and the 
Lagos State University Hospital, Lagos (LASUTH).  
Full term asphyxiated neonates with gestational age ≥ 37
weeks were consecutively recruited. Asphyxia was de-
fined based on double criteria of five minute Apgar 
score ≤ 6 and umbilical arterial blood pH < 7.2. The 
controls were normal non-asphyxiated term neonates 
matched for age, birth weight and sex. Echocardiogram 
was done to exclude congenital heart disease in allcases 
and controls. All babies were examined between 1–6 
hours of life for heart rate, heart rhythm irregularities, 
peripheral pulse volume, respiratory rate, pallor, cyano-
sis, heart murmur and sensorium. Written and verbal 
consent was obtained from at least one parent. Approval 





pH: was measured using Ion Selective Electrode (ISE) 
electrolyte analyser 6000 manufactured by SFRI France. 
 
Cardiac Troponin-T test 
 
The bedside kit, Cobas h232 ® system manufactured by 
ROCHE, England was used. The result of cTnT analysis 
is stratified by the Cobas h232 system manufacturer as 
low risk (< 0.03ng/ml), medium risk (0.03 to 0.1ng/ml) 
and high risk (> 0.1ng/ml). For high risk results (> 
0.1ng/ml), absolute values were displayed on the equip-
ment while for low and medium risk values, results were 
displayed as ‘< 0.03ng/ml’ or ‘0.03 to 0.1ng/ml” respec-
tively. A high risk result is synonymous with a positive 




ALOKA Prosound 4000 ® ultrasound diagnostic equip-
ment was used with the multi frequency paediatric 





A pre-designed proforma was used to record both clini-
cal and laboratory data for all eligible newborns. Data 
was analyzed using EP1 info 2008 version 3.5.1. Chi 
square test (Pearson) and odds ratios with 95% confi-
dence intervals were used to test for statistical signifi-
cance with respect to discrete data while Student t- tes  
was used for continuous data. Probability value less than 






A total of thirty asphyxiated and thirty non asphyxiated 
babies who met the study criteria were recruited from 
December 2009 to May 2010.  
 
General description of study population 
 
Subjects and controls were similar in distribution of gen-
der, mode of delivery, and birth weight (table 1). Chi-
square analysis of mode of delivery has been limited to 
caesarean section and spontaneous vertex delivery be-
cause of the small number of patients in the other wo 
groups. Also chi-square analysis for birth weight was 
limited to the first two groups (1500-2499g and 2500-
3499g) because of the small number of patients in the 
third group. The mean gestational age of primary sub-
jects was similar to that of controls (39.0 ± 1.5 weeks Vs 
38.4 ±1.2 weeks, t = 1.65, p = 0.1). The mean birth 
weight was 3168 ± 628.5g and 3143 ± 574.1g, respec-
tively for subjects and controls (p = 0.87). 
 
 
Table 1: Selected general characteristics of subjects and  
Controls 
Variable                      Subjects             Controls        Total 
         n = 30                  n = 30         n = 60 
Gender*  
Male        17 (56.7)  17 (56.7)       34 (56.7) 
Female         13 (43.3)           13 (43.3)       26 (43.3) 
Mode of delivery**    
Spontaneous vertex       16 (53.3)           10 (33.3)       26 (43.3) 
Caesarean section       12 (40.0)           20 (66.7)       32 (53.3) 
Breech           1 (3.3)                0 (0.0)      1 (1.7) 
Vacuum extraction           1 (3.3)    0 (0.0)      1 (1.7) 
Birth weight (gm) *** 
1500- 2499       6 (20.0)  6 (20.0)       12 (20.0) 
2500-3999       22 (73.3)  22 (73.3)       44 (73.7) 
≥ 4000        2 (6.7)                 2 (6.7)       4 (13.3) 
  
*  χ2 = 0.00, p = 1.00 (degrees of freedom=1) 
**  χ2 = 3.32, p = 0.07 (degrees of freedom=1)  
***  χ2 = 0.00, p = 1.00 (degrees of freedom=1)     
Figures in brackets are percentages of n. 
 
pH: 
The mean level of pH for the subjects and controls were 
7.11 ± 0.08 and 7.26 ± 0.04 respectively. 
 
Serum cTnT: 
Asphyxiated subjects were significantly more likely to 
have high risk test results than controls (p = 0.00, table 
2).  The association between the Apgar score and the 
serum cTnT level is depicted in figures 1 and 2. All 
thirty subjects had Apgar scores in the range of 4 – 6 at 
five minutes.  
 
Table 2: Distribution of Serum cTnT test results 
 
Serum cTnT (ng/ml)       Subjects  Controls    
               
 < 0.03          4 (13.3) 26 (86.7) 
0.03 – 0.10         6 (20.0)  4 (13.3) 
> 0.10        20 (66.7)  0 (0.0) 
Total        30 (100.0) 30(100.0) 
∗χ2 = 30.0, p = 0.00 (degrees of freedom = 2) 
Figures in brackets are percentages of column total  
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Fig 1: Association between serum cTnT risk level and 
Apgar score at one minute for subjects 
Fig 2: Association between serum cTnT risk level and 
Apgar score at five minutes for subjects 
Clinical findings and serum level of cTnT 
 
For ease of analysis, two groups of study population were recognised; those with abnormal cTnT test result (cTnT > 
0.1ng/ml) and those with cTnT ≤ 0.1ng/ml.  
Central cyanosis, reduced pulse volume, pallor, depressed sensorium; tachycardia and tachypnea were all associated 
with increased odds ratios for abnormal cardiac troponin T levels. (OR=0.0, 0.0, 107, 0.0, 0.11 and 0.24 respectively: 
table 3) 
Table 3: Associations between clinical findings and troponin level 
 
Elevated serum cTnT level 
   Present  Absent  Odds ratio 95% confidence limit
No (%)  No (%)    
 
Heart rate (beats/min)  
<120   2(50.0)  0 (0.0)  undefined 
120 – 160  9 (20.0)  36 (80.0)                 refer nce group 
>160   9 (69.2)  4 (30.8)  0.11*  0.02 – 0.53 
Regularity of heart rate 
Regular    19 (32.2)                40 (67.8)   
Irregular   1 (100.0)                 0 (0.00)  0.00  0.00 - 8.81 
Pulse volume 
Full   2 (5.6)  34 (94.4)                reference group  
Moderate                 15 (71.4)                 6 (28.6)  0.02*  0.00 – 0.15  
Small    3 (100.0)                0 (100.0)           0.00*  0.00 – 0.24 
Murmur 
Present   1 (50.0)  1 (50.0)   
Absent   19 (32.8)                39 (67.2)          0.49  0.01 – 19.05 
Respiratory rate (cycles/min)  
<30   1 (100.0)                0 (100.0)           undefined 
30 – 60   10 (23.3)                33 (76.7)           reference group   
>60   9 (56.3)  7 (43.7)  0.24*  0.06 – 0.92 
Pallor 
Present    19 (76.0)                  6 (24.0)  107.67*  11.0 – 2611.25 
Absent    2 (2.9)  34 (97.1)  
Central Cyanosis 
Present    20 (74.1)                    7 (25.9)  0.00*  0.00 – 0.07 
Absent    0 (0)                33 (100.0)     
Sensorium 
Alert    (0)    28 (100)  
Depressed  20 (62.5)                  12 (37.5)              0.00*  0.00 – 0.13 
 
Figures in brackets are percentages of row total 
* Significant  
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Discussion 
 
Myocardial ischaemia does occur in perinatal asphyxia. 
Serum cTnT is a biochemical marker of myocardial cell 
death.6, 10 and 11.  The current study focused on correlating 
selected physical findings with presence of elevated 
cTnT as a means of enhancing the diagnosis of asphyxia 
related myocardial ischaemia in resource poor healt 
facilities where equipment for estimation of serum cTnT 
may not be available routinely. 
The physical findings which were of high clinical inter-
est include tachypnoea, tachycardia, cyanosis, low pulse 
volume, pallor and depressed sensorium. All these fa-
tures had significant odds of elevated cTnT. This may be 
explained by varying severities of circulatory failure 
(shock) in affected neonates. This finds support in he 
report of Clarke and colleagues12 that hypotensive sick 
infants had significantly higher troponin T concentra-
tions than the normotensive sick counterparts. Myocar-
dial ischaemia causes shock which manifests with low 
pulse volume, tachycardia, tachypnoea, cyanosis, pal-
lor.9 Depressed sensorium is an indication that hypoxic 
ischaemic encephalopathy has occurred.8 Therefore, 
even though the initial dive reflex preferentially sustains 
perfusion of the brain, the heart and adrenals, as as-
phyxia progresses, these vital organs eventually becom  
compromised with consequent organ damage.  
 
It is striking to also note that while there are guidelines 
for the evaluation of hypoxic ischaemic encephalopathy 
in perinatal asphyxia, there is no similar guidelin for 
myocardial ischaemia in perinatal asphyxia. Meanwhile, 
such guidelines could be derived from simple but  
focused physical examination which is very cost effec-
tive. The predominant profile associated with an  
increased cTnT in our study is that of a term baby with 
perinatal asphyxia who develops pallor, cyanosis, 
tachypnoea, tachycardia, low volume peripheral pulses 
and depressed sensorium within the first few hours of 
delivery. This profile is not uncommon in most practice 
settings in developing countries and without doubt, it is 
beneficial that physicians begin to include myocardial 
ischaemia in the assessment of asphyxiated newborns. 
Future studies may derive scoring or grading system 
that will form a guideline for assessment of perinatal 
asphyxia related myocardial infarction. There is no
doubt that adequate cardiovascular monitoring as well as 
adequate fluid and shock management could reduce 
morbidity and improve asphyxia related mortality in 
affected babies. Overall, tackling neonatal mortality 
related to asphyxia could go a long way in meeting he 
nation’s Millennium Development Goal (MDG- 4) 
which focuses on reducing childhood mortality.15 
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